Corpus Intelligence IC Memo — OGLETHORPE OF ORLANDO INC. 2026-04-26 11:19 UTC
IC Memo — OGLETHORPE OF ORLANDO INC.
Investment Committee Memorandum | FL | 64 beds | Grade C | EBITDA uplift $933K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

OGLETHORPE OF ORLANDO INC.

CCN 104081 | OSCEOLA, FL | 64 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

OGLETHORPE OF ORLANDO INC. is a 64-bed community hospital in OSCEOLA, FL with $12.6M in net patient revenue and a 18.7% operating margin. The hospital serves a payer mix of 70.1% Medicare, 0.0% Medicaid, and 29.9% commercial.

Thesis: Turnaround. Our ML models identify $933K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 18.7% to 26.1% (+738bps).

Net Revenue HCRIS$12.6M
Current EBITDA COMPUTED$2.4M
Operating Margin COMPUTED18.7%
Occupancy HCRIS74.7%
Revenue / Bed COMPUTED$198K
Net-to-Gross HCRIS46.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
109
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 18.7% places it above the state median. Among 109 size-comparable peers (32-128 beds), the median margin is 4.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (32-128), prioritizing same-state peers. 109 hospitals in the comp set.

HospitalStateBedsRevenueMargin
OGLETHORPE OF ORLANDO INC. (Target)FL64$12.6M18.7%
WEST KENDALL BAPTIST HOSPITALFL127$361.6M18.5%
ADVENTHEALTH PALM COASTFL99$285.7M8.1%
ASCENSION SACRED HEART BAYFL126$192.1M-6.7%
ASCENSION SACRED HEART EMERALDFL80$187.9M16.1%
LAKEWOOD RANCH MEDICAL CENTERFL120$171.1M10.4%
HCA FLORIDA LAKE CITY HOSPITALFL113$168.8M34.4%
SOUTH FLORIDA BAPTIST HOSPITALFL128$164.1M2.6%
VIERA HOSPITAL INCFL84$162.9M16.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $933K (738bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$265K+210bp18mo
Cost to Collect4.5%2.5%$253K+200bp12mo
Denial Rate Reduction12.0%6.5%$252K+199bp12mo
A/R Days Reduction5200.0%3800.0%$154K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+8bp6mo

5. EBITDA Bridge

Net Collection Rate
$265K
Cost to Collect
$253K
Denial Rate Reduction
$252K
A/R Days Reduction
$154K
Clean Claim Rate
$10K
Total EBITDA Uplift$933K
Current EBITDA$2.4M
+ RCM Uplift+$933K
Pro Forma EBITDA$3.3M
Current Margin18.7%
Pro Forma Margin26.1%
WC Released (1x)$485K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$3.6M$25.0M6.85x46.9%
Base (11x exit)10.0x11.0x$3.6M$28.6M7.86x51.0%
Bull Case9.0x11.0x$3.3M$32.9M10.03x58.6%
Bull (12x exit)9.0x12.0x$3.3M$36.8M11.24x62.2%
Bear Case11.0x10.0x$4.0M$19.1M4.77x36.7%
Bear (11x exit)11.0x11.0x$4.0M$22.3M5.57x41.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 70.1% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 109 hospitals with 32-128 beds
  • Same-state prioritization (n=110)
  • Comp margins: P25=-9.7% / P50=4.8% / P75=12.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.